» Articles » PMID: 3311359

Production of Lipolytic and Proteolytic Factors by a Murine Tumor-producing Cachexia in the Host

Overview
Journal Cancer Res
Specialty Oncology
Date 1987 Nov 15
PMID 3311359
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Animals given transplants of the MAC16 colon adenocarcinoma show a progressive decrease in carcass weight as the tumor size increases without a reduction in either fluid or caloric intake when compared with non-tumor-bearing controls. There is a decrease in both carcass fat and muscle mass which is directly proportional to the weight of the tumor. In male animals weight loss occurs when the tumor mass comprises more than 0.3% of the body weight and reaches 30% when the tumor represents 3% of the body weight. There is evidence for the production by the tumor of both lipolytic and proteolytic factors, which may be responsible for the cachexia, since two related mouse adenocarcinomas, which do not produce weight loss, have little lipolytic or proteolytic activity. The lipolytic factor is nondialyzable and is destroyed by both heat and acid. Both insulin and 3-hydroxybutyrate suppress the lipolytic activity of the tumor extract. The MAC16 tumor also contains a serine protease, the activity of which is also completely abolished by insulin and 3-hydroxybutyrate. Animals bearing the MAC16 tumor have an elevated plasma lipolytic and proteolytic activity when compared with non-tumor-bearing controls, suggesting a peripheral effect of the tumor products. The catabolic factors elaborated by the MAC16 adenocarcinoma may be responsible for the loss of both the fat and nonfat carcass mass, but they do respond to normal metabolic controls.

Citing Articles

The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males.

Morena da Silva F, Lim S, Cabrera A, Schrems E, Jones R, Rosa-Caldwell M BMC Genomics. 2023; 24(1):374.

PMID: 37403010 PMC: 10318789. DOI: 10.1186/s12864-023-09462-7.


Human Papillomavirus 16-Transgenic Mice as a Model to Study Cancer-Associated Cachexia.

Peixoto da Silva S, Santos J, Mestre V, Medeiros-Fonseca B, Oliveira P, Bastos M Int J Mol Sci. 2020; 21(14).

PMID: 32708666 PMC: 7404304. DOI: 10.3390/ijms21145020.


Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review.

Rosa-Caldwell M, Fix D, Washington T, Greene N J Appl Physiol (1985). 2019; 128(1):25-41.

PMID: 31725360 PMC: 6985812. DOI: 10.1152/japplphysiol.00622.2019.


Reduction of splenic immunosuppressive cells and enhancement of anti-tumor immunity by synergy of fish oil and selenium yeast.

Wang H, Chan Y, Li T, Bauer B, Hsia S, Wang C PLoS One. 2013; 8(1):e52912.

PMID: 23349693 PMC: 3551929. DOI: 10.1371/journal.pone.0052912.


C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients.

Punzi T, Fabris A, Morucci G, Biagioni P, Gulisano M, Ruggiero M Mol Diagn Ther. 2012; 16(2):115-24.

PMID: 22497530 DOI: 10.1007/BF03256436.